Liposome-containing intranasal vaccine formulation
US5756104A · kind A · utility
24Cited by
12References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 1995 |
| Grant date | May 26, 1998 |
| Priority date | — |
| Expiry date | Jun 5, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/18434
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a vaccine formulation for intranasal or inhalation administration, and to the preparation thereof, which formulation contains antigenic material freely mixed with empty liposomes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.